Available option
2mg
Lyophilised powder
- Strength
- 2mg
- Format
- Lyophilised powder
Bear Biotech catalogue
CJC-1295 (with DAC)
Long-acting GHRH analogue with drug-affinity-complex research material
- GHRH receptor signalling
- GH/IGF-I dynamics
- Albumin association
Available presentations
Choose a strength and format
Each available presentation is listed separately. Current prices are confirmed from the Bear Biotech catalogue.
Research overview
What is CJC-1295 (with DAC)?
CJC-1295 with DAC is designed for prolonged GHRH-receptor stimulation through drug-affinity-complex chemistry and albumin association. Human endocrine studies reported extended GH and IGF-1 responses, making the DAC form scientifically distinct from short-acting CJC-1295 No DAC. The two identities should never be treated as interchangeable. Published findings concern defined DAC study material and do not establish equivalence for generic research material.
Controlled human endocrine studies exist for long-acting CJC-1295; still distinct from generic supplier material.
Research focus
Key research areas
CJC-1295 with DAC research: long-acting GHRH signalling
CJC-1295 with DAC is a long-acting GHRH analogue designed to associate with albumin. It is chemically and pharmacologically distinct from CJC-1295 No DAC. Published findings concern defined experimental materials and do not establish the identity, quality, safety, efficacy or equivalence of Bear Biotech catalogue material.
- GHRH receptor signalling
- GH/IGF-I dynamics
- Albumin association
Representative primary research
Representative research
Research examines prolonged GHRH receptor stimulation, GH secretion, IGF-I responses, pulsatility and biomarker changes.
- Prolonged GH and IGF-I stimulation by CJC-1295 ↗ Randomised healthy-adult studies of long-acting CJC-1295 with DAC; not evidence for No-DAC material or catalogue equivalence.
- GH pulsatility persists during CJC-1295 stimulation ↗ Healthy-men endocrine study of long-acting CJC-1295 with DAC; not evidence for No-DAC material or catalogue equivalence.
- Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects ↗ Human biomarker study of long-acting CJC-1295 with DAC; not identity proof for catalogue material.
These sources provide research context only. They do not verify the identity, quality or equivalence of a Bear Biotech catalogue batch; the matched lot-specific batch record remains controlling.
Specifications
Product information
- Material identity
- CJC-1295 (with DAC)
- Research category
- Long-acting GHRH analogue with drug-affinity-complex research material
- Evidence position
- Controlled human endocrine studies exist for long-acting CJC-1295; still distinct from generic supplier material.
- Recorded formats
- Lyophilised powder
- Batch-record basis
- The matched lot-specific record controls identity and analytical claims.
- Intended use
- Controlled laboratory research only.
Research questions
Evidence and identity questions
How does the Drug Affinity Complex change CJC-1295 research design?
CJC-1295 with DAC is researched as a long-acting GHRH-receptor agonist with albumin association. This identity is distinct from CJC-1295 No DAC.
What does albumin association contribute to GH and IGF-I studies?
GH and IGF-I dynamics are measured over time to examine the effect of the Drug Affinity Complex on persistence. Study design must preserve the exact DAC-containing sequence.
Why must CJC-1295 with DAC remain distinct from CJC-1295 No DAC?
The DAC form is designed to associate with albumin and persist longer, while CJC-1295 No DAC is a distinct short-acting identity without the Drug Affinity Complex. Evidence for one form cannot be applied to the other, and neither establishes equivalence for generic supplier material.
Batch documentation
Lot-specific records stay connected to the order
Eligible lot-specific documentation may be viewed or requested from the registered Bear Biotech account when available for the applicable order.
Open Bear Biotech accountResearch use only
Controlled laboratory research material
Not for human or veterinary consumption. Administration, dosing and therapeutic guidance are not provided.